Kathleen Goin, Chief Operating Officer at PALVELLA THERAPEUTICS, INC. (PVLA), sold 4,302 shares at $151.16 ($655K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Scheduled sale ($655k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.16 | 1,659 | $251K | 38.3% |
| 2 | $152.36 | 989 | $151K | 23.0% |
| 3 | $153.24 | 1,654 | $253K | 38.7% |
| Total | $152.24 avg | 4,302 | $655K | 100% |
| Filing → |
| PVLA | SELL | 2026-06-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-05-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-04-17 | $547K | — | Filing → |